Business Context and Reporting Period
Company: Alnylam Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 17, 2018
Event Date: August 14, 2018
Context: The Company entered into a Sixth Amendment to its existing lease agreement for office and laboratory space located at 300 Third Street, Cambridge, Massachusetts.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on the terms of a material definitive agreement regarding real estate.
| Item | Details |
|---|---|
| Lease Term Extension | Extended by 12 years and 4 months; new expiration date is January 31, 2034. |
| Renewal Options | Option to extend for two additional five-year terms. |
| Annual Rent (Starting Oct 2021) | $10.5 million (exclusive of operating expenses and real property taxes). |
| Rent Escalation | 2.5% annual increase thereafter. |
| Tenant Improvement Allowance | Up to $8.4 million provided by the Landlord. |
| Space Size | Approximately 129,000 square feet. |
Material Changes Versus Prior Period
The primary material change is the extension of the lease term. Previously, the lease was set to expire on September 30, 2021. Under the Sixth Amendment, the term now extends through January 31, 2034. Additionally, the agreement establishes a fixed rent structure beginning in October 2021 and introduces a significant tenant improvement allowance not present in the prior lease terms.
Guidance, Outlook, and Risks
Management Commentary: The filing provides no forward-looking financial guidance or strategic outlook beyond the execution of the lease amendment.
Risks and Contingencies: The filing notes that the description of the Sixth Amendment is not complete and is qualified by reference to the full agreement, which is expected to be filed as an exhibit to the Quarterly Report on Form 10-Q for the quarter ended September 30, 2018. The Company assumes the obligation of a long-term non-cancelable lease commitment.
Important Facts for Investor Verification
- Verify the total committed lease obligation over the extended term (through 2034) including the 2.5% annual rent escalations.
- Confirm the specific conditions and usage restrictions for the $8.4 million tenant improvement allowance.
- Review the full Sixth Amendment text in the upcoming Form 10-Q for any covenants or termination rights not detailed in this summary.
- Assess the impact of the new rent structure ($10.5 million starting in 2021) on future operating expenses relative to current cash burn rates.